Press review
The essentials of recent medical publications, unpacked by our newsroom into a clear, sourced digest, specialty by specialty.
Allergology and ImmunologyAllergies: the molecular revolution is underway
By Ana Espino | Published on January 29, 2026 | 3 min readAllergic diseases affect approximately 30 to 40% of the global population, with an increasing prevalence. They are caused by an inappropriate IgE-mediated immune response to normally harmless allergens, leading to clinical manifestations ranging from rhinitis to anaphylaxis. Management currently relies on allergen avoidance, symptomatic tre
OphthalmologyLaser and glaucoma: a high-pressure duel
By Ana Espino | Published on January 28, 2026 | 3 min readGlaucoma is a chronic, progressive optic neuropathy, most often associated with elevated intraocular pressure (IOP), leading to irreversible visual field loss. It represents the second leading cause of blindness worldwide, with an increasing burden related to population aging. When medical treatments are insufficient or poorly tolerated, an
HematologyZanubrutinib: toward a new era in CLL?
By Ana Espino | Published on January 27, 2026 | 3 min readChronic lymphocytic leukemia (CLL) is a malignant hematologic disorder characterized by the slow but progressive accumulation of mature B lymphocytes in the blood, bone marrow, and lymphoid organs. Although often indolent at onset, the disease may evolve into more aggressive forms, with an increased risk of infections, bone marrow failure,
RhumatologyWhat if osteoarthritis were an immune disease?
By Ana Espino | Published on January 26, 2026 | 3 min readOsteoarthritis is the most common joint disease, affecting over 300 million people worldwide. Long viewed as a simple consequence of mechanical cartilage wear, it is now recognized as a complex disorder involving mechanical, metabolic, and immune factors. Current treatments remain symptomatic: analgesics, non-steroidal anti-inflammatory dru
InfectiologyWhy Thalidomide Remains Unavoidable
By Ana Espino | Published on January 23, 2026 | 3 min readLeprosy is a chronic infectious disease caused by Mycobacterium leprae, primarily affecting the skin and peripheral nerves. It is characterized by a clinical spectrum closely linked to the host immune response. Erythema nodosum leprosum (ENL) is one of the major complications of the disease. This type 2 inflammatory reaction, occurring in a
InfectiologyLeprosy: a disease still beyond control
By Ana Espino | Published on January 22, 2026 | 3 min readLeprosy is a chronic infectious disease caused by Mycobacterium leprae, characterized by marked clinical, immunological, and evolutionary heterogeneity. Despite a substantial reduction in global prevalence following the introduction of multidrug therapy (MDT), annual incidence rates remain stable, indicating ongoing transmission. Current tr
Cardiology and Vascular MedicineHoliday Heart: when alcohol takes control of the heart’s rhythm
By Ana Espino | Published on January 21, 2026 | 3 min readHoliday Heart Syndrome (HHS) refers to the sudden onset of atrial fibrillation (AF) or other arrhythmias in people with no known heart disease. It often occurs after excessive alcohol consumption, particularly during holidays or long weekends.AF is a common and potentially serious arrhythmia. It increases the risk of blood clots, stroke and
Endocrinology and MetabolismObesity: when the kidneys become overwhelmed
By Ana Espino | Published on January 20, 2026 | 3 min readObesity is a chronic condition that is rapidly increasing worldwide and is associated with numerous metabolic, cardiovascular and renal complications. Among these complications, obesity-related glomerulopathy (ORG) is a still poorly understood condition characterized by moderate proteinuria, glomerular hypertrophy and progression to chronic
AddictologyParental alcohol intoxication: the hidden impact on children’s mental health
By Carolina Lima | Published on January 19, 2026 | 3 min readAs physicians, we often focus on the direct health consequences of alcohol use: liver disease, cardiovascular risk, addiction. But what about the silent victims in the room: the children?A recent longitudinal study from Norway (Journal of Child & Adolescent Trauma, 2024) brings attention on an overlooked issue: the impact of parental alc
NeurologymicroRNAs to diagnose ADHD?
By Ana Espino | Published on January 16, 2026 | 3 min readAttention-deficit/hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders in children, affecting approximately 5.2% of children worldwide. Despite this high prevalence, diagnosis relies mainly on subjective clinical assessments, which can lead to diagnostic errors or delays in management. Available treatments, a
AddictologyDepression: What if the solution were on the plate?
By Ana Espino | Published on January 15, 2026 | 3 min readMajor depressive disorder (MDD) is one of the most common and disabling psychiatric disorders worldwide. It affects quality of life, increases suicide risk, and represents a heavy burden on healthcare systems. Although conventional antidepressants are the first-line treatment, their effectiveness remains partial and inconsistent, with non-r
AddictologyAlcohol: No safe dose
By Ana Espino | Published on January 14, 2026 | 3 min readAlcohol use is a major risk factor for morbidity and mortality worldwide, contributing to more than 60 diseases, including cardiovascular diseases, cancers, liver cirrhosis, and neuropsychiatric disorders. Despite this well-documented burden, international recommendations regarding “moderate” levels of alcohol consumption remain controversi